Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1660135

	registered interest
	date	12/09/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment with Cabinet colleagues of the potential merits of extending the electricity grant available to people using medical equipment at home.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	199095
	answer	answer is ministerial correction date of answer 20/09/2023 answer text <p>My Rt hon. Friend, the Secretary of State for Health and Social Care, meets regularly with other Cabinet colleagues on a variety of matters pertaining to health and social care, including support for people using medical equipment at home.</p><p>As set out in the Autumn Statement, the Department for Energy Security and Net Zero are exploring the best approach to consumer protection, as part of wider retail market reforms. The Department of Health and Social Care and NHS England are supporting the Department for Energy Security and Net Zero in this.</p><p>An NHS England specialised commissioning team is working to support Department of Health and Social Care colleagues with identifying energy-reliant medical devices used in patients' homes, and identifying clinical expert nominees to advise more widely, as part of their operational response.</p><p>The Government continues to monitor the situation and will keep options under review, including with respect to the most vulnerable households.</p> answering member constituency Colchester answering member printed Will Quince question first answered 20/09/2023 10:00:03 answering member 4423 label Biography information for Will Quince
	tabling member	4131 label Biography information for Jim Shannon

1660144

	registered interest
	date	12/09/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the (a) funding and (b) amount of research undertaken on pregnancy.
	tabling member constituency	Enfield North
	tabling member printed	Feryal Clark
	uin	199224
	answer	answer is ministerial correction date of answer 20/09/2023 answer text <p>The Department commissions research through the National Institute for Health and Care Research (NIHR). Since 2018, approximately £68 million has been invested into research on pregnancy across NIHR’s research programmes. No assessment of the adequacy has been made and it is not usual practice for the NIHR to ringfence funds for particular topics or conditions. The NIHR welcomes funding applications for research into any aspect of human health, including pregnancy.</p> answering member constituency Colchester answering member printed Will Quince question first answered 20/09/2023 09:42:22 answering member 4423 label Biography information for Will Quince
	tabling member	4822 label Biography information for Feryal Clark

1660147

	registered interest
	date	12/09/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of commissioning research into the impact of haemochromatosis-related symptoms on people living with the condition.
	tabling member constituency	Slough
	tabling member printed	Mr Tanmanjeet Singh Dhesi
	uin	199103
	answer	answer is ministerial correction date of answer 20/09/2023 answer text <p>The Department commissions research through the National Institute for Health and Care Research (NIHR). The NIHR is not currently supporting research specifically on the impact of haemochromatosis-related symptoms on people living with this condition. However, the NIHR has funded a study on diagnostic strategies for haemochromatosis and is supporting research to improve diagnosis of haemochromatosis. The NIHR welcomes funding applications for research into any aspect of human health, including the impact of haemochromatosis-related symptoms on individuals.</p> answering member constituency Colchester answering member printed Will Quince question first answered 20/09/2023 10:00:49 answering member 4423 label Biography information for Will Quince
	tabling member	4638 label Biography information for Mr Tanmanjeet Singh Dhesi

1660420

	registered interest
	date	13/09/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Anticoagulants
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of variation in the management of anticoagulant-associated bleeds on patients.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	199332
	answer	answer is ministerial correction date of answer 20/09/2023 answer text <p>The clinical steps taken to address haemorrhage often vary from patient to patient and are influenced by a number of factors including but not limited to, the underlying indication for anticoagulation, the site of the bleed and its clinical consequences and the timing, volume and progression of the bleed. While no specific assessment has been made of the potential impact of variation in the management of anticoagulant-associated bleeds on patients, the Medicines and Healthcare products Regulatory Agency continually reviews the safety, efficacy and quality of medicines including treatments for anticoagulant associated bleeds, publishing drug safety updates where necessary to better inform clinicians and patients of the bleeding risk of anticoagulants.</p> answering member constituency Colchester answering member printed Will Quince question first answered 20/09/2023 09:51:27 answering member 4423 label Biography information for Will Quince
	tabling member	4131 label Biography information for Jim Shannon

1660153

	registered interest
	date	12/09/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps the NHS has taken to contact women who missed breast cancer screening appointments due to the covid-19 pandemic.
	tabling member constituency	Slough
	tabling member printed	Mr Tanmanjeet Singh Dhesi
	uin	199109
	answer	answer is ministerial correction date of answer 20/09/2023 answer text <p>All breast screening services are reporting that they have recovered from the impact of COVID-19.</p><p>To achieve this a number of steps have been taken, including:</p><p>- Breast Screening Offices running extra screening sessions and fully optimising available appointments to clear the mammogram backlog;</p><p>- developing a ‘NHS National Demand and Capacity Tool’ to support collation and analyses of data to identify where support and interventions are required;</p><p>- adapting mobile breast screening units so that women can be seen safely, in line with infection protection and control procedures;</p><p>- providers being encouraged to use methods such as text messaging to remind women about their breast screening invitation and encourage them to attend; and</p><p>- regional commissioners working closely with cancer alliances and cancer charities to develop uptake plans which address specific population needs.</p><p>In addition, the Department has invested £10 million of funding into the NHS Breast Screening Programme, providing 28 new breast screening units targeted at areas with the greatest challenges of uptake and coverage to boost uptake of screening in areas where attendance is low and tackle health disparities.</p> answering member constituency Colchester answering member printed Will Quince question first answered 20/09/2023 10:02:04 answering member 4423 label Biography information for Will Quince
	tabling member	4638 label Biography information for Mr Tanmanjeet Singh Dhesi

1660450

	registered interest
	date	13/09/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent estimate he has made of the number of women in (a) the South East and (b) England who have missed breast cancer screening appointments since March 2020.
	tabling member constituency	Slough
	tabling member printed	Mr Tanmanjeet Singh Dhesi
	uin	199417
	answer	answer is ministerial correction date of answer 20/09/2023 answer text <p>For the combined two-year period of 2020/21 and 2021/22, the available data shows that in the South East, 255,715 women invited did not attend their breast screening appointment; and in England, 1,863,100 women invited did not attend their breast screening appointment.</p><p> </p><p>More information is available at the following link:</p><p> </p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/breast-screening-programme" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/breast-screening-programme</a></p> answering member constituency Colchester answering member printed Will Quince question first answered 20/09/2023 11:23:33 answering member 4423 label Biography information for Will Quince
	tabling member	4638 label Biography information for Mr Tanmanjeet Singh Dhesi

1660818

	registered interest
	date	14/09/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to improve waiting times for cancer treatment in (a) Liverpool, Walton constituency and (b) England.
	tabling member constituency	Liverpool, Walton
	tabling member printed	Dan Carden
	uin	199634
	answer	answer is ministerial correction date of answer 20/09/2023 answer text <p>Reducing cancer treatment waiting times is a priority for this Government. The Department is working jointly with NHS England on implementing the delivery plan for tackling the COVID-19 backlogs in elective care. The Government plans to spend more than £8 billion from 2022/23 to 2024/25 to help drive up and protect elective activity, including cancer diagnosis and treatment activity.</p><p>In the 2023/24 Operational Planning Guidance, NHS England announced it is providing over £390 million in cancer service development funding to Cancer Alliances in each of the next two years to support delivery of the strategy and the operational priorities for cancer which includes increasing and prioritising diagnostic and treatment capacity for cancer.</p><p>Additionally, the Government recently published the Major Conditions Strategy Case for Change and Our Strategic Framework on 14 August 2023 which sets out our approach to making the choices over the next 5 years that will deliver the most value in facing the health challenges of today and of the decades ahead, including for cancer.</p> answering member constituency Colchester answering member printed Will Quince question first answered 20/09/2023 11:25:16 answering member 4423 label Biography information for Will Quince
	tabling member	4651 label Biography information for Dan Carden

1659109

	registered interest
	date	07/09/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Department of Health and Social Care: Buildings
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the total cost was of refurbishments to his Department's offices at 39 Victoria Street in the last 12 months; and what the procurement references were for these refurbishments.
	tabling member constituency	Ilford North
	tabling member printed	Wes Streeting
	uin	198375
	answer	answer is ministerial correction date of answer 20/09/2023 answer text <p>Alongside ongoing maintenance, within the last 12 months work has been carried out at 39 Victoria Street to remove a suite of individual ministerial offices and replace these with a flexible co-working space accessible by all members of staff that can also be used for large meetings.</p><p>Ministers now use desks on an open-plan floor alongside department staff.</p><p>Space has also been provided to allow NHS England staff to work in the Department to further improve collaboration between the two organisations.</p><p>This work has been undertaken alongside a wider programme to reduce the number of Department of Health and Social Care offices from 21 to 10 core locations, as well as a wider reform and efficiency programme, which has seen the Department’s headcount reduced by around one in six over the last year.</p><p>The total cost of refurbishment work at 39 Victoria Street was approximately £140,000. All work has been undertaken by existing facilities management contractors and within existing, pre-allocated, annual budgets for property maintenance.</p> answering member constituency Colchester answering member printed Will Quince question first answered 20/09/2023 12:46:41 answering member 4423 label Biography information for Will Quince previous answer version 94372 answering member constituency Colchester answering member printed Will Quince answering member 4423 label Biography information for Will Quince
	tabling member	4504 label Biography information for Wes Streeting

1660225

	registered interest
	date	12/09/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the adequacy of supply of medicines treating type-2 diabetes in the context of fluctuating levels of demand.
	tabling member constituency	Slough
	tabling member printed	Mr Tanmanjeet Singh Dhesi
	uin	199172
	answer	answer is ministerial correction date of answer 20/09/2023 answer text <p>We are aware of a supply issue with glucagon-like peptide-1 receptor agonists, which has been largely driven by off-label use for weight loss. We have issued guidance in the form of Medicine Supply Notifications and, on 18 July, issued a National Patient Safety Alert which made it clear that these medicines should only be prescribed for the treatment of type 2 diabetes, and should not be routinely prescribed for weight loss.</p><p>All prescribers, whether employed privately or by the National Health Service, are expected to take account of appropriate national guidance. It is for the responsible clinician to work with their patient and decide on the course of treatment, with the provision of the most clinically appropriate care for the individual always being the primary consideration.</p><p>We have engaged with relevant regulators, and the General Pharmaceutical Council, General Medical Council, Health and Care Professions Council, Nursing and Midwifery Council and Pharmaceutical Society of Northern Ireland have issued a joint statement stressing the importance of health and care professionals meeting regulatory standards.</p><p>We have also added Ozempic and other glucagon-like peptide 1 receptor agonists to the list of medicines that cannot be exported from, or hoarded in, the United Kingdom.</p><p>We are continuing to work closely with manufacturers and others working in the supply chain to help ensure the continued supply of these medicines for UK patients, for example by asking suppliers to expedite deliveries. We have provided advice for healthcare professionals on how to manage patients requiring this medicine whilst there are shortages and are keeping this under review as the situation evolves. If any patient is concerned about their treatment, they should discuss this with their clinician at the earliest opportunity.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 199402 question first answered 20/09/2023 09:58:51 answering member 4423 label Biography information for Will Quince
	tabling member	4638 label Biography information for Mr Tanmanjeet Singh Dhesi

1660432

	registered interest
	date	13/09/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to ringfence the supply of glucagon-like peptide 1 agonists medication for patients with type 2 diabetes.
	tabling member constituency	Slough
	tabling member printed	Mr Tanmanjeet Singh Dhesi
	uin	199402
	answer	answer is ministerial correction date of answer 20/09/2023 answer text <p>We are aware of a supply issue with glucagon-like peptide-1 receptor agonists, which has been largely driven by off-label use for weight loss. We have issued guidance in the form of Medicine Supply Notifications and, on 18 July, issued a National Patient Safety Alert which made it clear that these medicines should only be prescribed for the treatment of type 2 diabetes, and should not be routinely prescribed for weight loss.</p><p>All prescribers, whether employed privately or by the National Health Service, are expected to take account of appropriate national guidance. It is for the responsible clinician to work with their patient and decide on the course of treatment, with the provision of the most clinically appropriate care for the individual always being the primary consideration.</p><p>We have engaged with relevant regulators, and the General Pharmaceutical Council, General Medical Council, Health and Care Professions Council, Nursing and Midwifery Council and Pharmaceutical Society of Northern Ireland have issued a joint statement stressing the importance of health and care professionals meeting regulatory standards.</p><p>We have also added Ozempic and other glucagon-like peptide 1 receptor agonists to the list of medicines that cannot be exported from, or hoarded in, the United Kingdom.</p><p>We are continuing to work closely with manufacturers and others working in the supply chain to help ensure the continued supply of these medicines for UK patients, for example by asking suppliers to expedite deliveries. We have provided advice for healthcare professionals on how to manage patients requiring this medicine whilst there are shortages and are keeping this under review as the situation evolves. If any patient is concerned about their treatment, they should discuss this with their clinician at the earliest opportunity.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 199172 question first answered 20/09/2023 09:58:51 answering member 4423 label Biography information for Will Quince
	tabling member	4638 label Biography information for Mr Tanmanjeet Singh Dhesi